Europe Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2241 | Pages: 141 | May 2017 | Region: Europe


The Europe Cancer Biomarkers Market was worth USD 3 billion in 2016 and estimated to be growing at a CAGR of 11.2%, to reach USD 5.1 billion by 2021. Europe accounts for the second largest share in cancer biomarkers market.

Cancer biomarkers are generally biological molecules found in blood, other body fluids, or tissues that are a signal of a normal or abnormal process, or of a stipulation or disease. The cancer biomarkers are used for drug discovery and development, diagnostics, personalized medicine, and therapeutics. The most recent designed biomarkers and their applications give a great benefit in the cancer cases.

The cancer diagnostics market is driven by increasing commonness of different forms of cancer, growing cancer awareness, support of government initiatives and funding, and rise in healthcare expenditure. The introduction of non-invasive screening methods and novel diagnostic biomarkers are likely to create new revenue streams and fuel the cancer diagnostics market over the next five years. However, vague reimbursement scenario in certain countries and lack of specificity and sensitivity threaten to obstruct the growth of the cancer diagnostics market.

The Europe cancer biomarkers market is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on services market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the basis of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is segregated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is among omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies segment is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.

Based on geography, the market is analysed under various countries namely, U.K., Germany, France, Italy and Spain. U.K. is leading the cancer biomarkers market due to high incidence of cancer cases.

Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 Prostate Cancer    

                                5.1.3 Breast Cancer        

                                5.1.4 Lung Cancer            

                                5.1.5 Colorectal Cancer 

                                5.1.6 Cervical Cancer      

                                5.1.7 Other Cancers       

                                5.1.8  Y-o-Y Growth Analysis, By Disease               

                                5.1.9  Market Attractiveness Analysis, By Disease             

                                5.1.10  Market Share Analysis, By Disease            

                5.2 Services                       

                                5.2.1 Introduction           

                                5.2.2 Sample Preparation            

                                5.2.3 Assay development            

                                5.2.4 Biomarkers validation and testing 

                                5.2.5  Y-o-Y Growth Analysis, By Services              

                                5.2.6  Market Attractiveness Analysis, By Services            

                                5.2.7  Market Share Analysis, By Services             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Risk Assessment   

                                5.3.3 Development of molecular diagnostics       

                                5.3.4 Disease diagnosis 

                                5.3.5 Drug discovery      

                                5.3.6 Development and Drug formulation            

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 Protein Biomarkers             

                                5.4.3 Genetic biomarkers            

                                5.4.4 genetic biomarkers             

                                5.4.7  Y-o-Y Growth Analysis, By Type    

                                5.4.8  Market Attractiveness Analysis, By Type  

                                5.4.9  Market Share Analysis, By Type    

                5.5 Profiling Technologies                            

                                5.5.1 Omics technologies             

                                                5.5.1.1 Genomics

                                                5.5.1.2 Proteomics

                                                5.5.1.3 Metabolomics

                                                5.5.1.4 Transcriptomics

                                                5.5.1.5 Pharmacogenomics

                                5.5.2 Imaging technologies         

                                5.5.3 Immunoassays      

                                5.5.4 Cytogenetics          

                                5.5.5 Bioinformatics       

                                5.5.6 IVD multivariate index assays         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                

                                5.5.9  Market Share Analysis, By Profiling Technologies  

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Services

                                                6.1.3.4 By Application

                                                6.1.3.5 By Type

                                                6.1.3.6 Profiling Technologies

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Services

                                                6.1.4.4 By Application

                                                6.1.4.5 By Type

                                                6.1.4.6 Profiling Technologies

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Services

                                                6.1.5.4 By Application

                                                6.1.5.5 By Type

                                                6.1.5.6 Profiling Technologies

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Agendia Bv                 

                8.3 Biocurex Inc                               

                8.4 Biomerieux S.A.                        

                8.5 Biomoda Inc                               

                8.6 Astellas Pharma Us Inc                          

                8.7 Correlogic Systems Inc                           

                8.8 Beckman Coulter Inc                              

                8.9 Becton                          

                8.10 Dickinson And Company                     

                8.11 Clarient Inc                               

                8.12 Diadexus Inc                            

                8.13 Ambrilia Biopharma                              

                8.14 Affymetrix Inc                         

                8.15 Aureon Laboratories Inc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  2. Europe Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  3. Europe Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  4. Europe Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  5. Europe Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  6. Europe Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  7. Europe Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  8. Europe Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  9. Europe Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  10. Europe Assay development  Market By Region, From 2016-2021 ( USD Billion )
  11. Europe Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  12. Europe Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  13. Europe Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  14. Europe Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  15. Europe Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  16. Europe Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  17. Europe Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  18. Europe Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  19. Europe Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  20. Europe Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  21. Europe Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  22. Europe Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  23. Europe Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  24. Europe Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  25. Europe Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  26. Europe Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  27. Europe Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  28. Europe IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  29. U.K. Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  30. U.K. Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  31. U.K. Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  32. U.K. Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  33. U.K. Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  34. Germany Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  35. Germany Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  36. Germany Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  37. Germany Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  38. Germany Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  39. France Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  40. France Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  41. France Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  42. France Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  43. France Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  44. Italy Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  45. Italy Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  46. Italy Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  47. Italy Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  48. Italy Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  49. Spain Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  50. Spain Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  51. Spain Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  52. Spain Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  53. Spain Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  54. Europe Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  55. Europe Genomics Market By Region, From 2016-2021 ( USD Billion )
  56. Europe Proteomics Market By Region, From 2016-2021 ( USD Billion )
  57. Europe Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  58. Europe Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  59. Europe Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  60. U.K. Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  61. Germany Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  62. France Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  63. Italy Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  64. Spain Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
Middle East And Africa Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics)...
Latin America Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Appl...
Asia-Pacific Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Appli...
Europe Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Application...
North America Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Appl...
Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Applications (Rese...
Middle East And Africa Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User ...
Latin America Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmace...
Asia Pacific Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceu...
Europe Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical ...
North America Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmace...
Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Compani...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.